The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis
Recruiting
Observational Study
Primary Angle-Closure Glaucoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 50 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- Zhongnan Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Compared with primary angle-closure glaucoma (PACG) patients without zonular laxity and the control group, there are differentially expressed molecules in PACG patients with zonular laxity, and a potential mechanistic network can be constructed therefrom.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Clinically diagnosed with primary angle-closure glaucoma (PACG)
* Aged ≥ 50 years, no gender restriction
* Case Group A: Undergoing glaucoma surgery with intraoperatively confirmed significant zonular laxity
* Case Group B: Undergoing glaucoma surgery with intraoperatively con…
Contacts